Harlow, United Kingdom

Sylvie Bourrain


Average Co-Inventor Count = 4.5

ph-index = 3

Forward Citations = 52(Granted Patents)


Location History:

  • Harlow, GB (1997 - 2000)
  • High Easter, GB (2006)

Company Filing History:


Years Active: 1997-2006

Loading Chart...
8 patents (USPTO):Explore Patents

Title: Sylvie Bourrain: Innovator in Pharmaceutical Chemistry

Introduction

Sylvie Bourrain is a prominent inventor based in Harlow, GB. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target specific receptors in the brain. With a total of 8 patents to her name, her work has the potential to impact the treatment of various mental health conditions.

Latest Patents

Among her latest patents, Bourrain has developed sulfone derivatives that act as 5-HT7 receptor ligands. This invention relates to sulfone derivatives of a specific formula, which are useful in treating conditions susceptible to modulation of 5-HT receptor activity, such as depression and sleep disorders. Additionally, she has worked on azetidine, pyrrolidine, and piperidine derivatives that target the 5-HT1D receptor, further showcasing her innovative approach to pharmaceutical development.

Career Highlights

Bourrain is currently employed at Merck Sharp & Dohme Corporation, where she continues to advance her research and development efforts. Her career is marked by a commitment to improving therapeutic options for patients through innovative chemical solutions.

Collaborations

Some of her notable coworkers include Graham A Showell and Angus Murray MacLeod, with whom she has collaborated on various projects aimed at enhancing drug efficacy and safety.

Conclusion

Sylvie Bourrain's contributions to pharmaceutical chemistry exemplify the vital role of inventors in advancing medical science. Her innovative patents and ongoing research efforts continue to pave the way for new treatments in mental health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…